Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TXO Partners (TXO) Liabilities and Shareholders Equity (2022 - 2026)

TXO Partners has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $1.3 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 27.92% year-over-year to $1.3 billion; the TTM value through Mar 2026 reached $5.1 billion, up 32.29%, while the annual FY2025 figure was $1.4 billion, 31.44% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $1.3 billion at TXO Partners, down from $1.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.4 billion in Q3 2025 and troughed at $688.2 million in Q1 2024.
  • A 5-year average of $998.0 million and a median of $970.4 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 24.77% in 2023 and later soared 50.15% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $924.6 million in 2022, then fell by 24.77% to $695.6 million in 2023, then surged by 48.19% to $1.0 billion in 2024, then skyrocketed by 31.44% to $1.4 billion in 2025, then decreased by 2.44% to $1.3 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for TXO at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.